Columbia researchers have engineered probiotic bacteria that educate the immune system to destroy cancer cells, opening the door for a new class of cancer vaccines that take advantage of bacteria’s natural tumor-targeting properties. These microbial cancer vaccines can be personalized to attack each individual’s primary tumor and metastases, and may even prevent future recurrences.
Medical Xpress – latest medical and health news stories
